CVS tops estimates, hikes guidance as insurance business shows some improvement
Publishing timestamp: 2025-05-01 10:31:18
Summary
CVS Health reported better-than-expected revenue and profit for the first quarter, hiked its guidance, but remains cautious for the rest of the year due to higher medical costs and potential macro headwinds. The company's troubled insurance business showed some signs of improvement, but legal battles and charges related to Omnicare affected its GAAP diluted EPS guidance. CVS CEO mentioned potential impact from President Trump's planned tariffs on pharmaceuticals. CVS' performance was partially offset by charges related to anticipated losses in its insurance unit. CVS' retail pharmacy segment sales missed expectations, while its insurance business revenue exceeded estimates. CVS' health services segment also saw an increase in revenue. Aetna will stop offering health insurance plans on Affordable Care Act marketplaces starting in 2026.
Sentiment: MIXED
Tickers: CVS,
Keywords: biotechnology, business, donald trump, health care industry, cvs health corp, pharmaceuticals, breaking news: business, donald j. trump, biotech and pharmaceuticals, earnings, business news,
Source: https://www.cnbc.com/2025/05/01/cvs-health-cvs-earnings-q1-2025.html